CH614709A5 - - Google Patents

Info

Publication number
CH614709A5
CH614709A5 CH1243575A CH1243575A CH614709A5 CH 614709 A5 CH614709 A5 CH 614709A5 CH 1243575 A CH1243575 A CH 1243575A CH 1243575 A CH1243575 A CH 1243575A CH 614709 A5 CH614709 A5 CH 614709A5
Authority
CH
Switzerland
Application number
CH1243575A
Inventor
Jacques Dr Gosteli
Angelo Dr Storni
Armin Dr Zuest
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Priority to CH1243575A priority Critical patent/CH614709A5/xx
Priority to US05/723,125 priority patent/US4089960A/en
Priority to FR7628296A priority patent/FR2325374A1/fr
Priority to DE19762642331 priority patent/DE2642331A1/de
Priority to AU18061/76A priority patent/AU509392B2/en
Priority to IL50542A priority patent/IL50542A/xx
Priority to GB39514/76A priority patent/GB1555682A/en
Priority to CA261,875A priority patent/CA1074799A/en
Priority to ES451784A priority patent/ES451784A1/es
Priority to NL7610581A priority patent/NL7610581A/xx
Priority to NZ182161A priority patent/NZ182161A/xx
Priority to ZA765751A priority patent/ZA765751B/xx
Priority to HU76CI1687A priority patent/HU175215B/hu
Priority to AT710176A priority patent/AT360011B/de
Priority to BE170895A priority patent/BE846542A/xx
Priority to DK433076A priority patent/DK433076A/da
Priority to IE2120/76A priority patent/IE43730B1/en
Priority to JP51115321A priority patent/JPS5239681A/ja
Priority to AT883378A priority patent/AT358041B/de
Publication of CH614709A5 publication Critical patent/CH614709A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
CH1243575A 1975-09-25 1975-09-25 CH614709A5 (da)

Priority Applications (19)

Application Number Priority Date Filing Date Title
CH1243575A CH614709A5 (da) 1975-09-25 1975-09-25
US05/723,125 US4089960A (en) 1975-09-25 1976-09-14 Antiemetic, psychosomatic and antipsychotic heterocyclic pyridine carboxamides
FR7628296A FR2325374A1 (fr) 1975-09-25 1976-09-21 Nouveaux pyridinecarboxamides a substituant basique utiles comme medicaments
DE19762642331 DE2642331A1 (de) 1975-09-25 1976-09-21 Basisch substituierte pyridincarboxamide
AU18061/76A AU509392B2 (en) 1975-09-25 1976-09-23 Pyridinecarboxamides
IL50542A IL50542A (en) 1975-09-25 1976-09-23 Substituted pyridinecarboxamides,their manufacture and pharmaceutical compositions containing them
GB39514/76A GB1555682A (en) 1975-09-25 1976-09-23 Basically substituted pyridinecarboxamides
CA261,875A CA1074799A (en) 1975-09-25 1976-09-23 Process for the production of basically substituted alkoxypyridinecarboxamides
ES451784A ES451784A1 (es) 1975-09-25 1976-09-23 Procedimiento para la obtencion de piridincarboxamidas basi-camente sustituidas.
NL7610581A NL7610581A (nl) 1975-09-25 1976-09-23 Basisch gesubstitueerde pyridinecarboxamiden, alsmede werkwijzen voor het bereiden ervan en toepassing ervan.
NZ182161A NZ182161A (en) 1975-09-25 1976-09-24 Alkoxy-pyridine-carobxamide derivatives and pharmaceutical compositions
ZA765751A ZA765751B (en) 1975-09-25 1976-09-24 Basically substituted pyridine carboxamides
HU76CI1687A HU175215B (hu) 1975-09-25 1976-09-24 Sposob poluchenija novykh piridin-karboksamidov
AT710176A AT360011B (de) 1975-09-25 1976-09-24 Verfahren zur herstellung von neuen basisch substituierten pyridincarboxamiden und ihren saeureadditionssalzen
BE170895A BE846542A (fr) 1975-09-25 1976-09-24 Nouveaux pyridinecarboxamides a substituant basique utile comme medicaments
DK433076A DK433076A (da) 1975-09-25 1976-09-24 Fremgangsmade til fremstilling af basisk substituerede pyridincarboxamider
IE2120/76A IE43730B1 (en) 1975-09-25 1976-09-24 Basically substituted pyridiencarboxamides
JP51115321A JPS5239681A (en) 1975-09-25 1976-09-25 Basiccsubstituted pyridine carbonic acid amide and acid addition product preparation method thereof and medical mixture containing these compounds
AT883378A AT358041B (de) 1975-09-25 1978-12-12 Verfahren zur herstellung von neuen basisch substituierten pyridincarboxamiden und ihren saeureadditionssalzen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1243575A CH614709A5 (da) 1975-09-25 1975-09-25

Publications (1)

Publication Number Publication Date
CH614709A5 true CH614709A5 (da) 1979-12-14

Family

ID=4382994

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1243575A CH614709A5 (da) 1975-09-25 1975-09-25

Country Status (18)

Country Link
US (1) US4089960A (da)
JP (1) JPS5239681A (da)
AT (1) AT360011B (da)
AU (1) AU509392B2 (da)
BE (1) BE846542A (da)
CA (1) CA1074799A (da)
CH (1) CH614709A5 (da)
DE (1) DE2642331A1 (da)
DK (1) DK433076A (da)
ES (1) ES451784A1 (da)
FR (1) FR2325374A1 (da)
GB (1) GB1555682A (da)
HU (1) HU175215B (da)
IE (1) IE43730B1 (da)
IL (1) IL50542A (da)
NL (1) NL7610581A (da)
NZ (1) NZ182161A (da)
ZA (1) ZA765751B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2440946A2 (fr) * 1978-01-20 1980-06-06 Ile De France Nouveaux benzamides heterocycliques substitues, leurs procedes de preparation et leur application comme modificateurs du comportement
FI74707C (fi) * 1982-06-29 1988-03-10 Sandoz Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara alkylenoeverbryggade piperidylestrar eller -amider av bicykliska karboxylsyror.
FR2529548A1 (fr) * 1982-07-02 1984-01-06 Delalande Sa Nouveaux derives de l'amino-3 quinuclidine, leur procede et leur application en therapeutique
DE3429830A1 (de) * 1983-08-26 1985-03-07 Sandoz-Patent-GmbH, 7850 Lörrach Automatische carbonsaeure- und sulfonsaeureester oder -amide
US4593034A (en) * 1984-04-06 1986-06-03 A. H. Robins Company, Inc. 2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamides and thiobenzamides
DK40890D0 (da) * 1990-02-16 1990-02-16 Ferrosan As Substituerede urinstofforbindelser, deres fremstilling og anvendelse
MX9206075A (es) * 1991-10-24 1993-04-01 Smithkline Beecham Plc Nuevos compuestos antagonistas del receptor 5-hidroxitriptamina y composiciones farmaceuticas que los contienen
JP4113602B2 (ja) * 1997-04-04 2008-07-09 株式会社資生堂 ピロリジン誘導体及び抗潰瘍剤、抗菌剤
EP1478646A1 (en) * 2002-02-20 2004-11-24 PHARMACIA & UPJOHN COMPANY Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
DK1679003T3 (da) * 2003-10-31 2015-05-11 Ishihara Sangyo Kaisha Baktericid sammensætning og fremgangsmåde til bekæmpelse af plantesygdom

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2748134A (en) * 1956-05-29 Amide-like derivatives of piperidine
US3105072A (en) * 1963-09-24 Preparation thereof
JPS4940459B1 (da) * 1970-12-21 1974-11-02
BG21602A3 (da) * 1972-06-01 1976-07-20
PH9265A (en) * 1972-06-02 1975-07-30 J Monier A method of preparing 2-alkoxy-4,5-substituted benzamides
US3970663A (en) * 1973-05-02 1976-07-20 Science Union Et Cie, Societe Francaise De Recherche Medical Certain amino-nicotinamide derivatives
FR2252336B1 (da) * 1973-11-27 1977-03-04 Ile De France
US3933830A (en) * 1974-09-10 1976-01-20 Pfizer Inc. Process for the synthesis of 4-(2-pyridylamido ethyl) piperidines

Also Published As

Publication number Publication date
IL50542A0 (en) 1976-11-30
BE846542A (fr) 1977-03-24
DE2642331A1 (de) 1977-04-07
IE43730B1 (en) 1981-05-06
IL50542A (en) 1980-06-30
GB1555682A (en) 1979-11-14
AU509392B2 (en) 1980-05-08
JPS5239681A (en) 1977-03-28
FR2325374A1 (fr) 1977-04-22
HU175215B (hu) 1980-06-28
IE43730L (en) 1977-03-25
AU1806176A (en) 1978-04-06
US4089960A (en) 1978-05-16
NZ182161A (en) 1978-11-13
ATA710176A (de) 1980-05-15
DK433076A (da) 1977-03-26
AT360011B (de) 1980-12-10
CA1074799A (en) 1980-04-01
ZA765751B (en) 1977-08-31
ES451784A1 (es) 1977-09-01
FR2325374B1 (da) 1979-01-12
NL7610581A (nl) 1977-03-29

Similar Documents

Publication Publication Date Title
FR2317443B1 (da)
JPS5620016B2 (da)
JPS5258385U (da)
FR2315197B1 (da)
FR2313058B1 (da)
JPS572348B2 (da)
JPS5248776U (da)
JPS51105087A (da)
JPS5427092Y2 (da)
AU486537B2 (da)
JPS51115308U (da)
JPS51151511U (da)
JPS51108404U (da)
JPS5275072U (da)
BG23244A1 (da)
CH603701A5 (da)
CH574340A5 (da)
CH588069A5 (da)
BG23092A1 (da)
BG22982A1 (da)
BG22864A1 (da)
BG22693A1 (da)
BG22116A1 (da)
BG22022A1 (da)
BG21783A1 (da)

Legal Events

Date Code Title Description
PL Patent ceased